4.6 Article

Blood eosinophil count in the general population: typical values and potential confounders

期刊

EUROPEAN RESPIRATORY JOURNAL
卷 55, 期 5, 页码 -

出版社

EUROPEAN RESPIRATORY SOC JOURNALS LTD
DOI: 10.1183/13993003.01874-2019

关键词

-

资金

  1. Municipal Department of Health and Environment of Vienna
  2. Federal State Governmental Department of Health of Lower Austria
  3. Ludwig Boltzmann Society
  4. GlaxoSmithKline
  5. Novartis Pharma
  6. Menarini Pharma
  7. Air Liquide Health Care
  8. Pfizer
  9. Boehringer Ingelheim
  10. AstraZeneca
  11. Chiesi Farmaceutici SpA
  12. Teva
  13. MSD

向作者/读者索取更多资源

There is growing interest in blood eosinophil counts in the management of chronic respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). Despite this, typical blood eosinophil levels in the general population, and the impact of potential confounders on these levels have not been clearly defined. We measured blood eosinophil counts in a random sample of 11 042 subjects recruited from the general population in Austria. We then: 1) identified factors associated with high blood eosinophil counts (>75th percentile); and 2) excluded subjects with these factors to estimate median blood eosinophil counts in a healthy sub-population (n=3641). We found that: 1) in the entire cohort, age <= 18 years (OR 2.41), asthma (OR 2.05), current smoking (OR 1.72), positive skin prick test (OR 1.64), COPD (OR 1.56), metabolic syndrome (OR 1.41), male sex (OR 1.36) and obesity (OR 1.16) were significantly (p<0.05) associated with high blood eosinophil counts (binary multivariable logistic regression analysis), and had an additive effect; and 2) after excluding these factors, in those older than 18 years, blood eosinophil counts were higher in males than in females (median 120 (5%-95% CI: 30-330) versus 100 (30-310) cells.mu L-1, respectively) and did not change with age. Median blood eosinophil counts in adults are considerably lower than those currently regarded as normal, do not change with age beyond puberty, but are significantly influenced by a variety of factors which have an additive effect. These observations will contribute to the interpretation of blood eosinophil levels in clinical practice.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据